ROCK EDWIN (Chief Medical Officer) purchased 81.2% of their position (305K shares) of CRESCENT BIOPHARMA, INC. on the open market
Open‑market purchase worth $78.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/24/2024ACC: 0001415889-24-017978
Officer· Chief Medical Officer
Since Sep 2022
+305K
Net shares
Net buyer
$78.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
305K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+190K
Price / share
$0.25
Trade value
$48.11K
% of position
50.6%
6/20/2024
375.40K→565.40K
Common Stock
Direct
Shares
+115K
Price / share
$0.27
Trade value
$30.72K
% of position
20.3%
6/21/2024
565.40K→680.40K
Total
Net shares
+305K
Net value
$78.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/20/2024 | P · Purchase | +190K | $0.25 | $48.11K | 50.6% | 375.40K | 565.40K |
| Common Stock Direct | 6/21/2024 | P · Purchase | +115K | $0.27 | $30.72K | 20.3% | 565.40K | 680.40K |
| Total | +305K | $78.82K | ||||||
Derivative Transactions0
No derivative transactions reported